149 MEDICAL INC
Bolton, MA · Founded 2017 · CIK 0001787145 · Medtech · Private
A non-invasive optical bedside monitor using diffuse correlation spectroscopy (DCS) to continuously measure cerebral blood flow in extremely premature infants.
- Grants
- $1.8M
- 4 awards
- Sector median: 1
- Raised
- $450K
- 2 Form D · Apr 2021
- 66 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $200,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants | $149,969 | |
| Private capital raised | Form D · SEC | $250,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and evaluation of diffuse correlation spectroscopy to monitor cerebral blood flow and detect intraventricular hemorrhage in extremely premature infants | $998,872 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature Infants | $542,164 | |
| Federal grant | Department of Health and Human Services · Phase II · Development and Evaluation of Diffuse Correlation Spectroscopy to Monitor Cerebral Blood Flow and Detect Intraventricular Hemorrhage in Extremely Premature Infants | $81,669 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 827 | Tetrous, Inc. | — | $2.2M |
| 828 | Sonex Health, Inc. | — | $22M |
| 829 | Virtech Bio, Inc. | — | $500K |
| 830 | 149 MEDICAL INC | — | $450K |
| 831 | AMORPHEX THERAPEUTICS HOLDINGS INC. | — | $265K |
| 832 | Neural Dynamics Technologies LLC | — | $240K |
| 833 | X-COR Therapeutics Inc | — | $200K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- George AbeDirector
- Antoniu FantanaDirector · Executive Officer
- William ShawDirector · Executive Officer
- Bernhard ZimmermannExecutive Officer
Patents
- Systems And Methods For Detecting Response To Non-invasive Electromagnetic Signalsapplication
- Systems And Methods For Detecting Responses To Non-invasive Electromagnetic Signalsapplication
- Systems And Methods For Detecting Response To Non-invasive Electromagnetic Signalsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.